These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15998093)

  • 1. Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery.
    Yinghuai Z; Peng AT; Carpenter K; Maguire JA; Hosmane NS; Takagaki M
    J Am Chem Soc; 2005 Jul; 127(27):9875-80. PubMed ID: 15998093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
    Ma L; Hamdi J; Wong F; Hawthorne MF
    Inorg Chem; 2006 Jan; 45(1):278-85. PubMed ID: 16390066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD; Panza L; Capitani D; Mannina L; Banzato A; Rondina M; Renier D; Rosato A; Crescenzi V
    Biomacromolecules; 2007 Feb; 8(2):552-9. PubMed ID: 17291079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferrin-loaded nido-carborane liposomes: tumor-targeting boron delivery system for neutron capture therapy.
    Miyajima Y; Nakamura H; Kuwata Y; Lee JD; Masunaga S; Ono K; Maruyama K
    Bioconjug Chem; 2006; 17(5):1314-20. PubMed ID: 16984142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
    Genady AR
    Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bispecific antibody mediated targeting of nido-carboranes to human colon carcinoma cells.
    Primus FJ; Pak RH; Richard-Dickson KJ; Szalai G; Bolen JL; Kane RR; Hawthorne MF
    Bioconjug Chem; 1996; 7(5):532-5. PubMed ID: 8889012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of neutral and zwitterionic 3-carboranyl thymidine analogues for boron neutron capture therapy.
    Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
    J Med Chem; 2005 Feb; 48(4):1188-98. PubMed ID: 15715485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physisorbed o-carborane onto lyso-phosphatidylcholine-functionalized, single-walled carbon nanotubes: a potential carrier system for the therapeutic delivery of boron.
    Yannopoulos SN; Zouganelis GD; Nurmohamed S; Smith JR; Bouropoulos N; Calabrese G; Fatouros DG; Tsibouklis J
    Nanotechnology; 2010 Feb; 21(8):85101. PubMed ID: 20097975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico carborane docking to proteins and potential drug targets.
    Calvaresi M; Zerbetto F
    J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular delivery and passive tumor targeting of a self-assembled nanogel containing carborane clusters for boron neutron capture therapy.
    Kawasaki R; Sasaki Y; Akiyoshi K
    Biochem Biophys Res Commun; 2017 Jan; 483(1):147-152. PubMed ID: 28039054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and properties of carborane-functionalized aliphatic polyester dendrimers.
    Parrott MC; Marchington EB; Valliant JF; Adronov A
    J Am Chem Soc; 2005 Aug; 127(34):12081-9. PubMed ID: 16117549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of gold nanoparticles functionalized with carboranes for application in Boron Neutron Capture Therapy.
    Ciani L; Bortolussi S; Postuma I; Cansolino L; Ferrari C; Panza L; Altieri S; Ristori S
    Int J Pharm; 2013 Dec; 458(2):340-6. PubMed ID: 24140178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of boron nanocapsules for neutron capture therapy.
    Nakamura H; Ueno M; Ban HS; Nakai K; Tsuruta K; Kaneda Y; Matsumura A
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
    Thirumamagal BT; Zhao XB; Bandyopadhyaya AK; Naranyanasamy S; Johnsamuel J; Tiwari R; Golightly DW; Patel V; Jehning BT; Backer MV; Barth RF; Lee RJ; Backer JM; Tjarks W
    Bioconjug Chem; 2006; 17(5):1141-50. PubMed ID: 16984121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
    Lai CH; Lin YC; Chou FI; Liang CF; Lin EW; Chuang YJ; Lin CC
    Chem Commun (Camb); 2012 Jan; 48(4):612-4. PubMed ID: 22114760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis and biochemical evaluation of thymidine analogues substituted with nido carborane at the N-3 position.
    Byun Y; Yan J; Al-Madhoun AS; Johnsamuel J; Yang W; Barth RF; Eriksson S; Tjarks W
    Appl Radiat Isot; 2004 Nov; 61(5):1125-30. PubMed ID: 15308203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.
    Yanagie H; Maruyama K; Takizawa T; Ishida O; Ogura K; Matsumoto T; Sakurai Y; Kobayashi T; Shinohara A; Rant J; Skvarc J; Ilic R; Kuhne G; Chiba M; Furuya Y; Sugiyama H; Hisa T; Ono K; Kobayashi H; Eriguchi M
    Biomed Pharmacother; 2006 Jan; 60(1):43-50. PubMed ID: 16260113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy.
    Bohl Kullberg E; Carlsson J; Edwards K; Capala J; Sjöberg S; Gedda L
    Int J Oncol; 2003 Aug; 23(2):461-7. PubMed ID: 12851696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unilamellar liposomes with enhanced boron content.
    Li T; Hamdi J; Hawthorne MF
    Bioconjug Chem; 2006; 17(1):15-20. PubMed ID: 16417247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.